$902.71
arrow_drop_down1.09%Key Stats | |
---|---|
Open | $917.76 |
Prev. Close | $912.75 |
EPS | 8.12 |
Next Earnings Date | Dec 11, 2024 |
LOW | HIGH | |
---|---|---|
Day Range | 893.00 | 927.90 |
52 Week Range | 516.57 | 972.53 |
Ratios | |
---|---|
EPS | 8.12 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?
This Big Move by Eli Lilly May Solve the Weight Loss Drug Market's Biggest Problem
Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
Battle Over Compounded Weight-Loss Medications - Sustainability and Regulation
Eli Lilly's Once-Weekly Insulin Shows Non-Inferior Blood Sugar Reduction Vs Frequently Used Daily Insulins In Long Term Trials
Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.